Economic evaluation of FENO measurement in diagnosis and 1-year management of asthma in Germany

Respiratory Medicine

Volumn 102, Issue 2, 2008, Pages 219-231

  Berg, Jenny ^a   Lindgren, Peter ^a,b  

^a i3 Innovus ^*  (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Asthma; Cost effectiveness; Diagnosis; Exhaled nitric oxide; Management

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; CORTICOSTEROID DERIVATIVE; LONG ACTING DRUG; NITRIC OXIDE; PREDNISONE;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; ECONOMIC EVALUATION; EXHALATION; GERMANY; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; COST-BENEFIT ANALYSIS; GERMANY; HUMANS; MIDDLE AGED; MODELS, ECONOMIC; NITRIC OXIDE; PRACTICE GUIDELINES AS TOPIC; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY;

EID: 37449021503     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.09.008     Document Type: Article

References (39)

1. Beasley R., Crane J., Lai C.K., and Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 105 2 Part 2 (2000) S466-S472
2. Stock S., Redaelli M., Luengen M., Wendland G., Civello D., and Lauterbach K.W. Asthma: prevalence and cost of illness. Eur Respir J 25 1 (2005) 47-53
3. Nationale Versorgungsleitlinie Asthma. 2006, Bundesärztekammer, AWMF, Kassenärztliche Bundesvereinigung.
4. British guideline on the management of asthma. Thorax, 2003; 58(Suppl 1):i1-94.
5. Silkoff P.E., Carlson M., Bourke T., Katial R., Ogren E., and Szefler S.J. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 114 5 (2004) 1241-1256
6. Alving K., Weitzberg E., and Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6 9 (1993) 1368-1370
7. van den Toorn L.M., Overbeek S.E., de Jongste J.C., Leman K., Hoogsteden H.C., and Prins J.B. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 164 11 (2001) 2107-2113
8. Payne D.N., Adcock I.M., Wilson N.M., Oates T., Scallan M., and Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 164 8 Part 1 (2001) 1376-1381
9. Jatakanon A., Lim S., Kharitonov S.A., Chung K.F., and Barnes P.J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53 2 (1998) 91-95
10. Berlyne G.S., Parameswaran K., Kamada D., Efthimiadis A., and Hargreave F.E. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 106 4 (2000) 638-644
11. Kharitonov S.A., Yates D.H., and Barnes P.J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 153 1 (1996) 454-457
12. Pijnenburg M.W., Bakker E.M., Hop W.C., and De Jongste J.C. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 172 7 (2005) 831-836
13. Jones S.L., Kittelson J., Cowan J.O., Flannery E.M., Hancox R.J., McLachlan C.R., et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 164 5 (2001) 738-743
14. Zacharasiewicz A., Wilson N., Lex C., Erin E., Li A., Hansel T., et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 171 10 (2005) 1077-1082
15. Alving K., Janson C., and Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res 7 (2006) 67
16. Magnussen H., Holz O., Sterk P.J., and Hargreave F.E. Noninvasive methods to measure airway inflammation: future considerations. Eur Respir J 16 6 (2000) 1175-1179
17. Drummond M., Sculpher M., Torrance G., O'Brien B., and Stoddart G. Methods for the economic evaluation of health care programmes. 3rd ed. (2005), Oxford University Press, Oxford
18. Detsky A.S., Naglie G., Krahn M.D., Redelmeier D.A., and Naimark D. Primer on medical decision analysis: part 2-building a tree. Med Decision Making 17 2 (1997) 126-135
19. Smith A.D., Cowan J.O., Filsell S., McLachlan C., Monti-Sheehan G., Jackson P., et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 169 4 (2004) 473-478
20. Smith A.D., and Taylor D.R. Is exhaled nitric oxide measurement a useful clinical test in asthma?. Curr Opin Allergy Clin Immunol 5 1 (2005) 49-56
21. Global Strategy for Asthma Management and Prevention. 2005. Global Initiative for Asthma.
22. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 9347 (2002) 1715-1721
23. Jayaram L., Pizzichini M.M., Cook R.J., Boulet L.P., Lemiere C., Pizzichini E., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 3 (2006) 483-494
24. Torrance G.W. Measurement of health state utilities for economic appraisal. J Health Econ 5 1 (1986) 1-30
25. Berkman N., Avital A., Breuer R., Bardach E., Springer C., and Godfrey S. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax 60 5 (2005) 383-388
26. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 21 (2005) 2163-2173
27. Berry M.A., Shaw D.E., Green R.H., Brightling C.E., Wardlaw A.J., and Pavord I.D. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy 35 (2005) 1175-1179
28. Andersson F., Stahl E., Barnes P.J., Lofdahl C.G., O'Byrne P.M., Pauwels R.A., et al. Adding formoterol to budesonide in moderate asthma-health economic results from the FACET study. Respir Med 95 6 (2001) 505-512
29. Tattersfield A.E., Postma D.S., Barnes P.J., Svensson K., Bauer C.A., O'Byrne P.M., et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 160 2 (1999) 594-599
30. Szende A., Svensson K., Stahl E., Meszaros A., and Berta G.Y. Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. Pharmacoeconomics 22 8 (2004) 537-547
31. Kind P., Dolan P., Gudex C., and Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 316 7133 (1998) 736-741
32. Burstrom K., Johannesson M., and Diderichsen F. Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy 55 1 (2001) 51-69
33. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 18 3 (1999) 341-364
34. Schramm B., Ehlken B., Smala A., Quednau K., Berger K., and Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 21 1 (2003) 116-122
35. Franklin P.J., Turner S.W., Le Souef P.N., and Stick S.M. Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax 58 12 (2003) 1048-1052
36. Franklin P.J., Stick S.M., Le Souef P.N., Ayres J.G., and Turner S.W. Measuring exhaled nitric oxide levels in adults: the importance of atopy and airway responsiveness. Chest 126 5 (2004) 1540-1545
37. Malmberg L.P., Turpeinen H., Rytila P., Sarna S., and Haahtela T. Determinants of increased exhaled nitric oxide in patients with suspected asthma. Allergy 60 4 (2005) 464-468
38. Menzies D., Nair A., and Lipworth B.J. Portable exhaled nitric oxide measurement: comparison with the "gold standard" technique. Chest 131 2 (2007) 410-414
39. McGill C., Malik G., and Turner S.W. Validation of a hand-held exhaled nitric oxide analyzer for use in children. Pediatr Pulmonol 41 11 (2006) 1053-1057